Remifentanil

In some countries, this medicine may only be approved for veterinary use.

In the US, Remifentanil (remifentanil systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia.

US matches:

• Remifentanil


• Remifentanil Intravenous


• Remifentanil Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N01AH06

CAS registry number (Chemical Abstracts Service)

0132875-61-7

Chemical Formula

C20-H28-N2-O5

Molecular Weight

376

Therapeutic Category

Opioid analgesic

Chemical Name

1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester

Foreign Names

• Remifentanilum (Latin)
• Remifentanil (German)
• Remifentanil (French)
• Remifentanilo (Spanish)

Generic Names

• Remifentanil (OS: BAN)
• GI 87084 X (IS: GlaxoWellcome)
• Remifentanil Hydrochloride (OS: USAN, BANM)
• GI 87084 B (IS: Glaxo)

Brand Names

• Ultiva
  Glaxo Wellcome, Tunisia; GlaxoSmithKline, South Africa; Abbott, Canada; Bioniche, United States; Glaxo SmithKline, Spain; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Argentina; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Brazil; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Egypt; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Greece; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Israel; GlaxoSmithKline, Iraq; GlaxoSmithKline, Iran; GlaxoSmithKline, Italy; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Jordan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Lebanon; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Panama; GlaxoSmithKline, Poland; GlaxoSmithKline, Portugal; GlaxoSmithKline, Qatar; GlaxoSmithKline, Serbia; GlaxoSmithKline, Saudi Arabia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Syria; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Yemen; Janssen Pharmaceutical K.K., Japan; Pharmacia, Romania



• Ultiva (veterinary use)
  Elan, United Kingdom

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.